Potential roles of bone marrow stem cells in stroke therapy

Regenerative Medicine

Volumn 2, Issue 4, 2007, Pages 417-423

  Mendez Otero, Rosalia ^a   de Freitas, Gabriel R ^a   André, Charles ^a   de Mendonça, Maria Lucia Furtado ^b   Friedrich, Mauricio ^c   Oliveira Filho, Jamary ^d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL PRÓ CARDÍACO   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Acute stroke; Adult stem cells; Bone marrow; Neurological diseases; Neuroprotection; Stroke therapy; Trophic factors

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABSENCE OF SIDE EFFECTS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN NERVE CELL; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MONONUCLEAR CELL; NEUROPROTECTION; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; REVIEW; STEM CELL MOBILIZATION; STROKE;

ADULT; BONE MARROW CELLS; CELL TRANSPLANTATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; HUMANS; STEM CELLS;

EID: 34548181304     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.2.4.417     Document Type: Review

References (48)

1. Strong K, Mathers C, Bonita R: Preventing stroke: saving lives around the world. Lancet Neurol. 6, 182-187 (2007).
2. André C, Curioni CC, Braga da Cunha C, Veras R: Progressive decline in stroke mortality in Brazil from 1980 to 1982, 1990 to 1992, and 2000 to 2002. Stroke 37(11), 2784-2789 (2006).
3. The National Institute of Neurological Disorders and Stroke t-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581-1587 (1995).
4. Lees KR, Dawson J: Advances in emerging therapies. Stroke 8, 219-221 (2007).
5. Roy NS, Cleren C, Singh SK, Yang L, Beel MF, Goldman SA: Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12(11), 1259-1268 (2006).
6. Soundararajan P, Miles GB, Rubin LL, Brownstone RM, Rafuse VF: Motoneurons derived from embryonic stem cells express transcription factors and develop phenotypes characteristic of medial motor column neurons. J. Neurosci. 26(12), 3256-3268 (2006).
7. Wernig M, Benninger F, Schmandt T et al.: Functional integration of Embryonic stem cell-derived neurons in vivo. J. Neurosci. 24(22), 5258-5268 (2004).
8. Buhnemann C, Scholz A, Bemreuther C et al.: Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 129(12), 3238-3248 (2006).
9. Akerud P, Canals JM, Snyder EY, Arenas E: Neuroprotection through delivery of glial cell line derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J. Neurosci. 21(20), 8108-8118 (2001).
10. Behrstock S, Ebert A, McHugh J et al.: Human neural progenitors deliver glial cell line derived neutrophic factor to parkinsonian rodents and aged primates. Gene Ther. 13(5), 379-388 (2006).
11. Klein SM, Behrstock S, McHugh J et al.: GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum. Gene Ther. 16(4), 509-521 (2005).
12. Freed CR, Greene PE, Breeze RE et al.: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344, 710-719 (2001).
13. Korbling M, Estrov Z: Adult stem cells for tissue repair - a new therapeutic concept? N. Engl. J. Med. 349, 570-582 (2003).
14. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294-1301 (2006).
15. Mezey E: Bone marrow-derived stem cells in neurological diseases stones or masons? Regen. Med. 2(1), 37-49 (2007).
16. Bliss T, Guzman R, Daadi M, Steinberg GF: Cell transplantation therapy for stroke. Stroke 38(2), 817-826 (2007).
17. Sykova E, Jandelova P: Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ. 14, 1336-1342 (2007).
18. Escolar ML, Poe MD, Provenzale JM et al.: Transplantation of umbilical-cord blood in babies with infantile Krabbeis disease. N. Engl. J. Med. 352(20), 2069-2081 (2005).
19. Sykova E, Homola A, Mazanec R et al.: Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant. 15(8-9), 675-687 (2006).
20. Perin EC, Dohmann HFR, Borojevic R et al.: Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107, 2294-2302 (2003).
21. Wollert KC Meyer GP, Lotz J et al.: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148 (2004).
22. Cho H-J, Lee J, Wecker A, Yoon Y: Bone marrow-derived stem cell therapy in ischemic heart disease. Regen. Med. 1(3), 337-345 (2006).
23. Pallante BA, Edelberg JM: Realizing the cardiac stem cell promise: a case for trophism. Regen. Med. 1(2), 217-221 (2006).
24. Kondziolka D, Wechsler L, Goldstein S et al.: Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55, 565-569 (2000).
25. Kondziolka D, Steinberg GK, Wechsler L et al.: Neurotransplantation for patients with subcortical motor stroke a Phase 2 ramdomized trial. J. Neurosurg. 103(1), 38-45 (2005).
26. Meltzer CC, Kondziolka D, Villemagne VL et al.: Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery 49(3), 586-591 (2001).
27. Nelson PT, Kondziolka D, Wechsler L et al.: Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am. J. Pathol. 160, 1201-1206 (2002).
28. Savitz SI, Dinsmore J, Wu J et al.: Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts a preliminary safety and feasibility study. Cerebrovasc. Dis 20, 101-107 (2005).
29. Gibson CL, Jones NC, Prior MJ et al.: G-CSF suppresses edema formation and reduces interleukin-1β expression after cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 64(9), 763-769 (2005).
30. Solaroglu I, Cahill J, Jedhav V et al.: A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 37, 1123-1128 (2006).
31. Schneider A, Kruger C, Steigleder T et al.: The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 115, 2083-2098 (2005).
32. Schabitz WR, Kruger C, Pitzer C et al.: A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J. Cereb. Blood Flow Metab. DOI 10.1038/ sj.jcbfm.9600496 (2007) (Epub ahead of print).
33. Ickenstein GW, Haas S, Sauerbruch S et al.: Regeneration in acute ischemic stroke (RAIS) with hematopoetic stem cell mobilization. Proceedings of the 56th Annual Meeting of the American Academy of Neurology. San Francisco, CA, USA, April 24-May 1, 2004.
34. Schabitz WR, Schneider A, Kollmar R et al.: Treatment with AX 200 (granulocyte-colony stimulating factor) for acute ischemic stroke (AXIS). International Stroke Conference, New Orleans, LA, USA (2005).
35. Shyu WC, Lin SZ, Lee CC et al.: Granulocyte colony-stimulating factor for acute ischemic stroke a randomized controlled trial. CMAJ 174, 927-933 (2006).
36. Sprigg N, Bath PM, Zhao L et al.: Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke. The Stem Cell Trial of Recovery EnhanceMent After Stroke (ST EM S) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 37(12), 2979-2983 (2006).
37. Schabitz W-R, Schneider A: New targets for established proteins exploring G-CSF for treatment of stroke. Trends Pharmacol. Sci. 28, 157-161 (2007).
38. Bang OY, Lee JS, Lee PH et al.: Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57(6), 874-882 (2005).
39. Mendonca ML, Freitas GR, Silva SA et al.: Safety of intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke. Arq. Bras Cardiol. 86(1), 52-55 (2006).
40. Correa P, Felix R, Mendonca ML et al.: Dual-head coincidence gamma camera FD G-PET before and after autologous bone marrow mononuclear cell implantation in ischaemic stroke. Eur. J. Nucl. Med. Mol. Imaging 32, 999 (2005).
41. Correa P, Mesquita CT, Felix R et al.: Assessment of bone marrow mononuclear cells distribution by radioactive labeling after stem cell therapy in acute ischemic stroke. Abstracts from the International Stroke Conference. Stroke 37, 647 (2006).
42. de Freitas GR, Mendonça MLF, Bezerra DC et al.: Safety and feasibility of intra-arterial autologous bone marrow mononuclear cell transplantation in acute ischemic stroke. Abstracts from the International Stroke Conference Stroke 37, 624-625 (2006).
43. de Freitas GR, Furtado-de-Mendonça ML, Bezerra DC et al.: Safety and feasibility of intra-arterial autologous bone marrow mononuclear cells transplantation in acute ischemic stroke. Proceedings of the 58th Annual Meeting of the American Academy of Neurology. San Diego, CA, USA, April 1-8, 2006.
44. Wang M, Crisostomo PR, Herring C et al.: Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am. J Physiol. Regul. Integr. Comp. Physiol. 291(4), 880-884 (2006).
45. Le Bras B, Barallobre MJ, Homman-Ludiye J et al.: VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 9(3), 340-348 (2006).
46. Pasinelli P, Brown RH: Molecular biology of amyotrophic lateral sclerosis insights from genetics. Nat. Rev. Neurosci. 7(9), 710-723 (2006).
47. Storkebaum E, Lambrechts D, Dewerchin M et al.: Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 8(1), 85-92 (2005).
48. Kilic U, Kilic E, Jarve A et al.: Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J. Neurosci. 26, 12439-12446 (2006).